| Stage | CTSH | % of rev | VRSN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.7B | 100.00% | $443M | 100.00% | CTSH ×12.79 |
| Gross profit | $1.9B | 33.77% | $393M | 88.76% | VRSN +55.0pp |
| Operating income | $872M | 15.40% | $297M | 66.93% | VRSN +51.5pp |
| Pre-tax income | $863M | 15.24% | $280M | 63.12% | VRSN +47.9pp |
| Net income | $627M | 11.07% | $213M | 47.99% | VRSN +36.9pp |
| Stage | CTSH | VRSN | Gap · A − B |
|---|---|---|---|
| Revenue | $5.7B100.00% | $443M100.00% | CTSH ×12.79 |
| Gross profit | 33.77%$1.9B | 88.76%$393M | VRSN +55.0pp |
| Operating income | 15.40%$872M | 66.93%$297M | VRSN +51.5pp |
| Pre-tax income | 15.24%$863M | 63.12%$280M | VRSN +47.9pp |
| Net income |
| 11.07%$627M |
| 47.99%$213M |
| VRSN +36.9pp |